Takeda Pharmaceutical Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
| Owner Type | Number of Shares | Ownership Percentage |
|---|---|---|
| Private Companies | 53,075 | 0.00338% |
| Public Companies | 275,000 | 0.0175% |
| Individual Insiders | 709,550 | 0.0452% |
| Company Controlled Foundation | 17,912,000 | 1.14% |
| Institutions | 746,913,805 | 47.6% |
| General Public | 803,070,421 | 51.2% |
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Top Shareholders
| Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
|---|---|---|---|---|---|---|
| 117,251,689 | US$3.0b | -3.95% | 0.06% | |||
| 69,397,200 | US$1.8b | 1.07% | 0.65% | |||
| 57,906,369 | US$1.5b | 1.21% | 0.03% | |||
| 50,891,334 | US$1.3b | -45.6% | 0.91% | |||
| 44,461,577 | US$1.2b | -30.7% | 0.06% | |||
| 36,509,500 | US$945.5m | 12.3% | 0.37% | |||
| 32,355,100 | US$837.9m | 1.19% | 0.66% | |||
| 32,253,604 | US$835.3m | -0.42% | 0.7% | |||
| 25,543,298 | US$661.5m | 5.33% | 0.06% | |||
| 24,752,000 | US$641.0m | 0% | 0.72% | |||
| 21,879,000 | US$566.6m | 0% | 1.66% | |||
| 19,149,100 | US$495.9m | -0.69% | 0.36% | |||
| 17,912,000 | US$463.9m | 0% | no data | |||
| 12,836,387 | US$332.4m | 3.06% | 0.03% | |||
| 8,419,838 | US$218.1m | 2.91% | 0.04% | |||
| 7,085,583 | US$183.5m | 12.3% | 0.04% | |||
| 6,742,972 | US$174.6m | 7.03% | 0.02% | |||
| 6,529,712 | US$169.1m | 0.03% | 0.11% | |||
| 5,944,622 | US$154.0m | -0.04% | 0.69% | |||
| 5,834,000 | US$151.1m | -1.34% | 0.13% | |||
| 5,729,500 | US$148.4m | 0.68% | 0.32% | |||
| 5,590,109 | US$144.8m | -7.8% | 0.04% | |||
| 5,149,500 | US$133.4m | -1.57% | 0.16% | |||
| 5,122,888 | US$132.7m | 4.33% | 0.02% | |||
| 4,975,540 | US$128.9m | 6.4% | 0.01% |